| Record ID | marc_columbia/Columbia-extract-20221130-014.mrc:50994792:3486 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-014.mrc:50994792:3486?format=raw |
LEADER: 03486cam a2200409Ia 4500
001 6729506
005 20221122045135.0
008 070907t20082008nyua b 101 0 eng d
010 $a 2007936362
020 $a9780387738970
020 $a0387738975
035 $a(OCoLC)ocn172984359
035 $a(OCoLC)172984359
035 $a(NNC)6729506
035 $a6729506
040 $aBTCTA$cBTCTA$dBAKER$dYDXCP$dBGU$dCLU$dCOU$dDLC$dCUS$dOrLoB-B
050 00 $aRC270.8$b.T34 2008
082 00 $a616.99/406$222
096 $aQZ 267$bT185 2008
245 00 $aTargeted therapies in cancer :$bmyth or reality? /$cFrancesco Colotta, Alberto Mantovani, editors.
260 $aNew York :$bSpringer,$c[2008], ©2008.
300 $aviii, 191 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAdvances in experimental medicine and biology ;$vv. 610
505 00 $tCausality in Medicine /$rGiulio Giorello -- $tThe Evolution of the Biomedical Paradigm in Oncology: Implications for Cancer Therapy /$rGilberto Corbellini and Chiara Preti -- $tAnticancer Drug Discovery and Development /$rFrancesco Colotta -- $tBeyond VEGF: Targeting Tumor Growth and Angiogenesis via Alternative Mechanisms /$rJames Christensen and Kenna Anderes -- $tAurora Kinases and Their Inhibitors: More Than One Target and One Drug /$rPatrizia Carpinelli and Jurgen Moll -- $tSignalling Pathways and Adhesion Molecules as Targets for Antiangiogenesis Therapy in Tumors /$rGianfranco Bazzoni -- $tDeveloping T-Cell Therapies for Cancer in an Academic Setting /$rMalcolm K. Brenner -- $tAnticancer Cell Therapy with TRAIL-Armed CD34+ Progenitor Cells /$rCarmelo Carlo-Stella, Cristiana Lavazza, Antonino Carbone and Alessandro M. Gianni -- $tLinking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies /$rAlberto Mantovani, Federica Marchesi, Chiara Porta, Paola Allavena and Antonio Sica -- $tClinical Development of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors: What Lessons Have We Learned? /$rManuel Hidalgo -- $tGIST As the Model of Paradigm Shift Towards Targeted Therapy of Solid Tumors: Update and Perspective on Trial Design /$rJaap Verweij, Caroline Seynaeve and Stefan Sleijfer -- $tMonoclonal Antibodies in the Treatment of Malignant Lymphomas /$rBertrand Coiffier -- $tMolecular Network Analysis using Reverse Phase Protein Microarrays for Patient Tailored Therapy /$rRuna Speer, Julia Wulfkuhle, Virginia Espina, Robyn Aurajo, Kirsten H. Edmiston, Lance A. Liotta and Emanuel F. Petricoin III.
500 $aCollection of contributions to a meeting held September 2005 in Milan.
504 $aIncludes bibliographical references and index.
650 0 $aCancer$xTreatment$vCongresses.$0http://id.loc.gov/authorities/subjects/sh2009118247
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
650 2 $aNeoplasms$xphysiopathology.$0https://id.nlm.nih.gov/mesh/D009369Q000503
650 2 $aAntineoplastic Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000970Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aColotta, Francesco.$0http://id.loc.gov/authorities/names/no2008034902
700 1 $aMantovani, Alberto.$0http://id.loc.gov/authorities/names/n89225330
830 0 $aAdvances in experimental medicine and biology ;$vv. 610.$0http://id.loc.gov/authorities/names/n42001229
852 00 $boff,hsl$hRC270.8$i.T34 2008